The effects of dietary supplementation with n‐3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial
- 1 October 1992
- journal article
- clinical trial
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 22 (10) , 687-691
- https://doi.org/10.1111/j.1365-2362.1992.tb01431.x
Abstract
Study objective: To determine the effect of dietary supplementation with n‐3 polyunsaturated fatty acids (n‐3 PUFA) on disease variables in patients with rheumatoid arthritis. Design: Multicenter, randomized, placebo controlled, double blind. Setting: Three Danish hospital Departments of Rheumatology. Patients: Fifty‐one patients with active rheumatoid arthritis. Intervention: Random allocation to 12 weeks of treatment with either six n‐3 PUFA capsules (3–6 g) or six capsules with fat composition as the average Danish diet. Main results: Significant improvement of morning stiffness and joint tenderness. No significant effect on the four other assessed clinical parameters. No serious side effects. Conclusions: Dietary supplementation with n‐3 PUFA in patients with rheumatoid arthritis improved two out of six patient reported disease parameters. Further studies are needed to clarify the more precise role of n‐3 PUFA in the treatment of rheumatoid arthritis.Keywords
This publication has 24 references indexed in Scilit:
- Dietary fish oil and olive oil supplementation in patients with Rheumatoid Arthritis clinical and immunologic effectsArthritis & Rheumatism, 1990
- Fish oil and rheumatoid arthritis: does a herring a day keep rheumatologists away?Annals of the Rheumatic Diseases, 1990
- Hand handicap and rheumatoid arthritis in a fish‐eating society (the Faroe Islands)Journal of Internal Medicine, 1990
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.Annals of the Rheumatic Diseases, 1988
- Serum amino‐terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosionsArthritis & Rheumatism, 1986
- Dietary fat modulation of immune responseInternational Journal of Immunopharmacology, 1986
- EFFECTS OF MANIPULATION OF DIETARY FATTY ACIDS ON CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITISThe Lancet, 1985